Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: Relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?
- 30 November 1994
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 17 (5) , 485-488
- https://doi.org/10.1016/0891-5849(94)90176-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tamoxifen and related compounds decrease membrane fluidity in liposomesFEBS Letters, 1993
- Clinical and Radiographic Response in a Minority of Patients with Recurrent Malignant Gliomas Treated with High-Dose TamoxifenNeurosurgery, 1993
- Does a genotoxic carcinogen contribute to human breast cancer?Mutagenesis, 1993
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- The Treatment of Intracranial Malignant Gliomas Using Orally Administered Tamoxifen TherapyNeurosurgery, 1992
- Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinomaDigestive Diseases and Sciences, 1992
- Effect of ascorbic acid and curcumin on quercetin-induced nuclear DNA damage, lipid peroxidation and protein degradationCancer Letters, 1992
- Overview From the International Conference on Long-Term Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1992
- The antioxidant action of tamoxifen and its metabolites Inhibition of lipid peroxidationFEBS Letters, 1990
- Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988